Skip to main content

Month: March 2023

Nkarta Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights

Clinical updates on track for NKX101 in first half of 2023 and NKX019 in full year 2023 2022 year-end cash and cash equivalents of $354.9 million Cash runway anticipated to fund operations into 2025SOUTH SAN FRANCISCO, Calif., March 16, 2023 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today reported financial results for the fourth quarter and year ended December 31, 2022. “Clinical data from our co-lead pipeline candidates have highlighted the promise of our allogeneic NK cell therapy technology to lead the next wave of cell therapy,” said Paul J. Hastings, President and CEO of Nkarta. “We believe that the future of cell therapy is improved accessibility, and NK cells may be uniquely equipped to overcome...

Continue reading

Eton Pharmaceuticals Reports Fourth Quarter 2022 Financial Results

Q4 2022 revenue of $8.5 million Q4 Product sales and royalty revenue up 220% from prior year and 9% from Q3 Q4 positive net income Management to hold conference call today at 4:30pm ETDEER PARK, Ill., March 16, 2023 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (“Eton” or “the Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the quarter ended December 31, 2022. “The fourth quarter was another impressive quarter for Eton, fueled by the continued momentum of ALKINDI SPRINKLE and Carglumic Acid. It was our eighth straight quarter of sequential revenue growth in product and royalty revenue, and we expect that strong growth to continue throughout 2023 and beyond,” said Sean Brynjelsen, CEO of Eton Pharmaceuticals. “Our...

Continue reading

Acutus Medical Reports Fourth Quarter and Full Year 2022 Financial Results

CARLSBAD, Calif., March 16, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today reported results for the fourth quarter and full year ended December 31, 2022. Financial statements and other information presented for 2022 is unaudited. Recent Highlights:Reported revenue of $5.0 million for the fourth quarter of 2022, a 14% increase compared to $4.4 million for the same quarter last year Reported revenue of $16.4 million for the full year of 2022, a 5% decrease compared to $17.3 million for the full year of 2021 Global mapping procedure volumes increased 19% for the full year of 2022, compared to the full year of 2021 Achieved key milestones under the asset purchase agreement with...

Continue reading

Correction: VEON publishes preliminary 4Q22 and FY22 results

VEON publishes preliminary 4Q22 and FY22 results Sale of Russia will lead to a significant reduction in debt Amsterdam, 16 March 2022: A correction has been issued for the release disseminated today at 07:00 CET.  The figure for EBITDA in FY 2022 highlights was inaccurately cited. The correct amount is USD 1,743 million. The complete and corrected release follows: Amsterdam, 16 March 2022 07:00 CET: VEON Ltd. (NASDAQ: VEON, Euronext Amsterdam: VEON), a global digital operator that provides converged connectivity and online services, announces selected financial and operating results for the fourth quarter and full year ended 31 December 2022, excluding the results of the Russian operations, as they were classified as ‘held for sale’ and ‘discontinued operations’ in 4Q22: In Q4 2022, VEON’s local currency performance accelerated sharply...

Continue reading

Vanguard Announces Cash Distributions for the Vanguard ETFs (VUN and VUS)

TORONTO, March 16, 2023 (GLOBE NEWSWIRE) — Vanguard Investments Canada Inc. today announced the final March 2023 cash distributions for certain Vanguard ETFs, listed below, that trade on Toronto Stock Exchange (TSX). Unitholders of record on March 24, 2023 will receive cash distributions payable on March 31, 2023. Details of the “per unit” distribution amounts are as follows:Vanguard ETF® TSX TickerSymbol Distributionper Unit ($) CUSIP ISIN PaymentFrequencyVanguard U.S. Total Market Index ETF VUN 0.227006 92206D100 CA92206D1006 QuarterlyVanguard U.S. Total Market Index ETF (CAD-hedged) VUS 0.225375 92206B104 CA92206B1040 QuarterlyTo learn more about the TSX-listed Vanguard ETFs, please visit www.vanguard.ca About Vanguard Canadians own CAD $72 billion in Vanguard assets, including Canadian and U.S.-domiciled ETFs and...

Continue reading

Teck’s Trail Operations Commits to the Zinc Mark

VANCOUVER, British Columbia, March 16, 2023 (GLOBE NEWSWIRE) — Teck Resources Limited (TSX: TECK.A and TECK.B, NYSE: TECK) (“Teck”) today announced Teck Trail Operations has committed to the Zinc Mark. The Zinc Mark is part of the Copper Mark’s multi-metals approach using the Copper Mark assurance framework, a framework which aims to promote responsible production practices and demonstrate the industry commitment to the United Nations Sustainable Development Goals. “Zinc has a critical role to play in the transition to a low-carbon economy. It is used for renewable energy storage and galvanizes the steel needed in everything from transit lines to wind turbines, making clean infrastructure last longer – and therefore more sustainable,” said Jonathan Price, CEO of Teck. “Participating in the Zinc Mark is part of our ongoing work...

Continue reading

Trillium Gold and Pacton Gold Combine to Create Dominant Strategic Land Position in Red Lake

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES         VANCOUVER, British Columbia, March 16, 2023 (GLOBE NEWSWIRE) — Trillium Gold Mines Inc. (TSXV: TGM, FRA: 0702) (“Trillium”) and Pacton Gold Inc. (TSXV: PAC, OTC: PACXF, FSE: 2NKM) (“Pacton”) are pleased to announce that they have entered into an arrangement agreement dated March 15, 2023 (the “Agreement”) to combine the two companies to create the leading gold explorer and dominant strategic land holder, over 15 projects covering over 1,260 km2 in the prolific Red Lake Mining District of Northern Ontario (the “Transaction”). Under the terms of the Agreement, Trillium and Pacton will merge on an at-market basis, with each common shareholder of Pacton (each, a “Pacton Shareholder”) entitled to receive 1.275 common shares of Trillium...

Continue reading

Clarification on the stress corrosion phenomenon detected on parts of the auxiliary circuits of the main primary circuit of several nuclear reactors

Clarification on the stress corrosion phenomenon detected on parts of the auxiliary circuits of the main primary circuit of several nuclear reactors On 10 March 2023, EDF proposed to the ASN (Nuclear safety authority) an evolution in its stress corrosion control strategy. EDF is accelerating the inspection of the concerned welds of the RIS and RRA systems, in order to include the elements identified on the weld repaired at Penly 11. The ASN announced today to have taken note of this evolution in the strategy, and to continue the technical dialogue with EDF to ensure the relevance of the planned schedule2. To date and on the basis of the control strategy proposed by EDF, the estimate of nuclear output in France for 2023 remains in the range 300-330TWh. This press release is certified. Check its authenticity on medias.edf.com About EDF As...

Continue reading

Danone publishes its 2022 Universal Registration Document

Press Release – Paris, March 16, 2023 Danone publishes its 2022 Universal Registration Document Danone filed its 2022 Universal Registration Document with the French Financial Markets Authority (Autorité des Marchés Financiers) on March 16, 2023. The 2022 Universal Registration Document includes notably:the Annual Financial Report; the Board of Directors’ report on the corporate governance; the description of the share buyback program; and the management report including non-financial performance statement.This 2022 Universal Registration Document is available to the public in accordance with applicable regulations and is also available on Danone’s website (www.danone.com), on the “Investors / Publications & events / Registration Documents/URD” section. The draft resolutions presented at the Shareholders’ Meeting on April 27,...

Continue reading

EnBW International Finance B.V. – Annual Report 2022

EnBW International Finance B.V.: Annual report 2022 In accordance with the Transparency Directive (Directive 2004/109/EC), as amended by the Transparency Directive Amending Directive (Directive 2013/50/EU), and following the choice of EnBW International Finance B.V. for the The Netherlands as Home Member State, EnBW International Finance B.V. hereby informs that the financial reports at year end 31 December 2022 have been filed on 16 March 2023 with the Autoriteit Financiële Markten (AFM) in the Netherlands and are available on https://www.enbw.com/media/downloadcenter/annual-financial-statement-of-enbw-international-finance-b-v/financial-report-2022-enbw-international-finance-b-v.pdf

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.